Anti-TACSTD2 (clone C16)-VC-MMAD ADC

This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (clone C16) conjugated via a VC linker to MMAD. The MMAD is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAD binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.